Brintellix is it addictive

The honest answer: no, Brintellix is not addictive in the classic sense, but it can cause a physical discontinuation syndrome, and in bipolar disorder the bigger risk is mood destabilization, not addiction.

Brintellix (vortioxetine) is a serotonin modulator, not a controlled substance. It does not produce euphoria, tolerance, or compulsive use, which are the hallmarks of addiction. The retrieved records contain no evidence of vortioxetine being scheduled, abused, or associated with dependence in the way benzodiazepines or stimulants are. What it can cause is a discontinuation syndrome if stopped abruptly: dizziness, headache, nausea, and irritability. That is physical dependence, not addiction. The distinction matters. Addiction is compulsive drug-seeking behavior; dependence is a withdrawal reaction when the drug is removed. Brintellix sits in the dependence category, like most antidepressants, not the addiction category.

For bipolar disorder specifically, the retrieved evidence is thin. One 2024 narrative review discusses anhedonia as a target for antidepressant therapy in alcohol-dependent patients, but it does not address vortioxetine or bipolar disorder directly [1]. A 2022 review of vortioxetine covers its adverse effects, including nausea, vomiting, constipation, and sexual dysfunction, but says nothing about addiction potential or bipolar-specific risks [2]. The retrieval contains no head-to-head trial of vortioxetine against lithium or anticonvulsants in bipolar patients, and no long-term data on whether it triggers mania more or less than other antidepressants.

The known class risk applies: antidepressants can induce mania or rapid cycling in bipolar patients. The retrieved records do not give a vortioxetine-specific rate. The 2023 survey of psychiatrists on benzodiazepine dependence is about a different drug class and does not inform vortioxetine [3]. The 2001 study on antidepressant-induced mania is about older agents, not vortioxetine [4].

My call: Brintellix is not addictive. It carries a discontinuation risk if stopped abruptly, and in bipolar disorder it carries the general antidepressant risk of mood destabilization, but the retrieved evidence gives no vortioxetine-specific numbers for either. Confidence: moderate on the addiction question, low on the bipolar-specific safety question, because the retrieval simply does not contain that data.